Home > Ophthalmics > Vendors > OCuSOFT

OCuSOFT: Delivering Innovative Eyelid Cleansers and Ophthalmic Products

CIO VendorThomas Mason, Executive Vice President
“Our underlying strategy is to deliver a wide variety of products in the ophthalmic market, ensuring that we cater to the needs of patients, as well as eye care professionals,” remarks Thomas Mason, Executive Vice President at OCuSOFT®. Established in 1986, OCuSOFT® continues to provide the first commercially available eyelid cleanser, OCuSOFT® Lid Scrub® Original. Prior to the availability of OCuSOFT® Lid Scrub®, doctors used to recommend diluted baby shampoo to treat blepharitis— inflammation of the eyelids—or for eyelid hygiene in general. This is what inspired the company to come up with a novel solution for eyelid cleansing which is non-irritating and safe to use around eyes. Although the company has regularly expanded its line of eyelid scrubs, OCuSOFT® Lid Scrub® Original Eyelid Cleanser remains the flagship product.

OCuSOFT® Lid Scrub® Original effectively removes oil, debris, and contaminants from the eyelids and eyelashes in order to treat blepharitis, dry eyes, or improve contact lens wearing comfort. OCuSOFT® Lid Scrub® Original needs to be rinsed off after use. “Patients are now more aware of the availability of dry eye treatments, which inspires us to invest more in R&D and develop new, innovative products for Dry Eye Syndrome,” adds Mason. As a consequence of this renewed focus on R&D, the company developed an advanced version of the eyelid cleanser—OCuSOFT® Lid Scrub® PLUS—which is a leave-on eyelid cleanser with anti-bacterial properties. “Our motto is to get better at our job every day along with focusing on convenience and quality of the products that we deliver at a reasonable price to both patients and doctors,” asserts Mason. This can be exemplified by how the company has recently launched OCuSOFT® Lid Scrub® PLUS Platinum which has anti-inflammatory properties to get rid of the redness associated inflammation.

OCuSOFT® Lid Scrub® Original removes oil, debris, and contaminants from the eyelids to treat blepharitis, dry eyes, or improve contact lens wearing comfort


OCuSOFT® delivers these products via subsidiary companies or distributors, depending on the market. For instance, OCuSOFT® UK handles the distribution in the UK, whereas in Southeast Asia, the role is assigned to distributors. Among the diverse Southeast Asian markets, Thailand grabs a major share of clients, with China being an emerging sector. The company’s clients include doctors who practice individually as well as conglomerates of ophthalmology and optometry practices. OCuSOFT® contacts every single account in its database on a monthly basis, making an effort to understand their pain points along with providing relevant products in a timely manner and delivering optimum value. “Our objective is to form relationships with practitioners and continue effective communication with them,” states Mason. OCuSOFT® also customizes its products to meet a customer’s unique requirements or even develops entirely new ones if need be.

OCuSOFT®’s customer-centric approach is further strengthened by the idea of ‘ownership thinking’ that is promulgated throughout the company. Every employee, regardless of their role, takes the ownership of the tasks they perform and the results that follow, while constantly contributing to customer satisfaction. To ensure the quality of products, the company gathers regular feedback from both its customers as well as employees. As a result, OCuSOFT® has been named a ‘Top Work Place’ by the Houston Chronicle for seven consecutive years and a ‘Best Place to Work’ by the Houston Business Journal for three consecutive years.

In addition to being a top workplace for employees, OCuSOFT® aims to become a top vendor for various ophthalmology and optometry practices in the market. “We also look forward to spreading more awareness about dry eye syndrome outside the US while continuing to innovate, building relationships with clients, and developing novel products,” concludes Mason.